Aaron J Grossberg
Aaron J Grossberg is an expert in Oncology at Oregon Health and Science University Hospital (United States). Aaron J Grossberg has authored 124 publications, the most recent in 2026, and is an investigator in 4 clinical trials, 2 of them ongoing. SLR score: 644 (community average: 125). How the SLR is computed.
LeadR Profile
Oncology
Subspecialties: Nutrition - Endocrinology - Gastroenterology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2009 - 2026
Number : 124
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| The post-transcriptional regulator HuR promotes immune evasion in pancreatic ductal adenocarcinoma. PMID 42696395 — nutrients, cells, genes, growth, neoplasms, adenocarcinoma, immunotherapy, food, immune evasion | Cancer Immunol Res | 2026 | 0 |
| Pancreatic cancer cachexia promotes cardiac dysfunction through altered adrenergic signalling in the heart. PMID 42464935 — sympathetic nervous system, adrenergic agents, physiology, pancreatic neoplasms, heart rate, heart, stress, physiological, neoplasms, receptors, adrenergic, cachexia, cancer-associated cachexia | J Physiol | 2026 | 0 |
| Pancreatic Cancer Early Detection Biomarkers for High-Risk Individuals: Insights From the PRECEDE Consortium. PMID 42298760 — pancreatic neoplasms, early detection of cancer, neoplasms, biopsy, biomarkers, signs and symptoms, diagnosis, liquid biopsy | Int J Cancer | 2026 | 0 |
| Nutritional management practices and perspectives of Radiation Oncologists: outcomes of an International Atomic Energy Agency survey. PMID 42255981 — radiation oncologists, oncologists, body composition, nutritional status, nuclear energy | Clin Transl Radiat Oncol | 2026 | 0 |
| Interleukin 6 drives durable T cell-mediated immunity to pancreatic cancer. PMID 41850678 — cells, pancreatic neoplasms, neoplasms, interleukin-6, immunity, cellular, pancreas, cell line, histology, immunity, gastrointestinal diseases, t-lymphocytes, lipid nanoparticles | Cell Mol Gastroenterol Hepatol | 2026 | 0 |
Clinical Studies 4
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 1
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer NCT06958328 — leucovorin, radiotherapy, taxes, cells, research design, albumin-bound paclitaxel, pancreatic neoplasms, uracil, blood, paclitaxel, nanoparticles, tomography, liposomes, positron-emission tomography, neoplasms, adenocarcinoma, magnetic resonance imaging, biopsy, drug therapy, positron emission tomography computed tomography, oxaliplatin, fluorouracil, pancreas, calcium, specimen handling, therapeutics, capecitabine, artificial intelligence, tissues, irinotecan, camptothecin, chemotherapy | Phase 3 | Recruiting | 2025 |
| Body Composition Changes After TIPS and Associated Clinical Outcomes NCT05420753 — hypertension, liver transplantation, stents, portasystemic shunt, transjugular intrahepatic, muscles, blood, liver cirrhosis, fibrosis, heart, radiologists, hepatic veins, body composition, portal vein, liver, portasystemic shunt, surgical, hypertension, portal, transplants, frailty, veins, needles, transplantation, catheters, blood vessels, sarcopenia | Early Phase 1 | Recruiting | 2022 |
LeadR Networks
Main global connection map